Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-17

FDA Approved: ROFLUMILAST — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved an original application for roflumilast from Aurobindo Pharma Limited, enabling a generic version of the COPD medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Roflumilast (roflumilast)

Snippet

ORIG AP for ROFLUMILAST (ROFLUMILAST)